Fetched: 2026-04-28T19:02:17+00:00 | Drug-level signals: 50 | Total public records checked: 1683
This email is the human-readable report. CSV/JSON remain export and integration artifacts for verification, internal tooling, and audit trails.
How to read this
FDA status is the status in the public shortage record. Why this appeared explains the watchlist or sample match path. Context sources found counts public source layers with usable context for verification. FormularySignal is flagging source records, not recommending an operational action.
Source-bound run brief
- 8 Signal Cards packaged with source context for internal review.
- 1683 public-record row changes detected since the previous snapshot.
- Highest public-record concentration in this run: Psychiatry, Anesthesia, Cardiovascular.
- Attached public context types in this run: DailyMed, RxNorm, openFDA NDC.
- Pattern notes are source-bound operational context only; they are not predictions, causality claims, medical advice, substitution guidance, inventory advice, procurement guidance, or legal advice.
Signal Card
Carboplatin Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 29 | Listed companies: 8 | Latest public update: 2026-04-24
Signal Card
Dexamethasone Sodium Phosphate Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 16 | Listed companies: 5 | Latest public update: 2026-04-23
Signal Card
Methotrexate Sodium Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 14 | Listed companies: 5 | Latest public update: 2026-04-23
Signal Card
Metronidazole Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 4 | Listed companies: 3 | Latest public update: 2026-04-27
Signal Card
Rocuronium Bromide Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 26 | Listed companies: 11 | Latest public update: 2026-04-21
Signal Card
Lidocaine Hydrochloride Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 70 | Listed companies: 10 | Latest public update: 2026-04-23
Signal Card
Dexmedetomidine Hydrochloride Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 53 | Listed companies: 14 | Latest public update: 2026-04-23
Signal Card
Midazolam Hydrochloride Injection
This watchlist term matched a public FDA/openFDA shortage record. Use the source links below for internal review.
FDA status Current |
Why this appeared Public-source sample record |
Context sources found 4 source layers found |
Public-record change: New public shortage record detected
Related public records: 30 | Listed companies: 6 | Latest public update: 2026-04-23
Category concentration
- Psychiatry: 245
- Anesthesia: 225
- Cardiovascular: 202
- Analgesia/Addiction: 131
- Anti-Infective: 84
- Oncology: 73
Boundaries
FormularySignal monitors public records and source context for verification. It does not provide medical advice, prescribing advice, substitution guidance, inventory recommendations, procurement recommendations, patient-specific workflows, causality claims, or FDA endorsement.
ASHP/UUDIS handling is external link/title/date context only. Bulletin content is not copied, summarized, rewritten, or used for synthesized reports.